Par Pharmaceutical Inc. Recall: Meclizine Hydrochloride Tablets USP, 25 mg Tablets, Packag
Par Pharmaceutical Inc. Recall: Meclizine Hydrochloride Tablets USP, 25 mg Tablets, Packag is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Par Pharmaceutical Inc.; Product: Meclizine Hydrochloride Tablets USP, 25 mg Tablets, Packaged in a) 100 Ct Bottles (NDC: 49884-035-01) and b) 1000
| Recalling firm | Par Pharmaceutical Inc. |
|---|---|
| Product | Meclizine Hydrochloride Tablets USP, 25 mg Tablets, Packaged in a) 100 Ct Bottles (NDC: 49884-035-01) and b) 1000 Ct Bottles (NDC: 49884-035-10), Rx only. Par Pharmaceutical Companies, Inc., Spring Valley, NY 10977. |
| Reason for recall | Failed Impurities/Degradation Specifications: Out of specification for impurities. |
| Classification | Class III (least serious — unlikely to cause adverse health consequences) |
| Status | Terminated |
| Distribution | U.S. Nationwide including Puerto Rico |
| Recall initiated | 20151026 |
| Recall number | D-0234-2016 |
| Category | drug |
| State | NY |
| Country | United States |
$29/mo
Try RecallGuard →